TIBET AIM PHARM
00282616.113.87% ( +0.60 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: TIBET AIM PHARM(002826) the Revenue is 182.58 M (+22.92%);the EBIT is 24.37 M (+14.66%);the EPS is 0.11 (+10%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.18B22.92%
----
----
EBIT
0.02B14.66%
----
----
EPS
0.1110.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf